Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds

• Status: Unknown status
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Banner Health
• Treatments: Morphine

Criteria

Inclusion Criteria:

• Signed and dated consent form & HIPAA

• > 18 yo

• Single stage 2-3 wound

• No allergy to morphine

• Alert and oriented (thinking ability clear and intact, physician approval)

• English language proficiency

Exclusion Criteria:

• Allergy to morphine, codeine, or versa base, pts taking medications for acute condition, other than for the wound pain

• Patients with neuropathies

• Patients with respiratory conditions